Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Interim Review

5 Jun 2006 15:44

Ark Therapeutics Group PLC05 June 2006 Ark Therapeutics Group plc 5 June 2006 SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN 1. Name of company Ark Therapeutics Group plc 2. Name of scheme Ark Therapeutics Group Unapproved Share Option Scheme (the "Scheme") 3. Period of return From 3/12/2005 to 2/6/2006 4. Number and class of shares(s) (amount of stock/debt security) not issued under the Scheme 907,401 ordinary shares of 1 pence each 5. Number of shares issued/allotted under the Scheme during period 36,250 6. Balance under the Scheme not yet issued/allotted at end of period 871,151 7. Number and class of share(s) (amount of stock/debt securities) originally listed and the date of admission 126,220,994 ordinary shares admitted to listing on 8/3/2004 Please confirm total number of shares in issue at the end of the period in order for us to update our records: 159,372,573 Contact for queries: Nick Plummer, Ark Therapeutics Group plc, 79 New Cavendish Street, London W1W 6XBTelephone: 0207 388 7722 Person making return:Name: Nick PlummerPosition: Company Secretary Ark Therapeutics Group plc 5 June 2006 SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN 1. Name of company Ark Therapeutics Group plc 2. Name of scheme Ark Therapeutics Group Enterprise Management Incentive Share Option Plan (the "Scheme") 3. Period of return From 3/12/2005 to 2/6/2006 4. Number and class of shares(s) amount of stock/debt security) not issued under the Scheme 277,016 ordinary shares of 1 pence each 5. Number of shares issued/allotted under the Scheme during period Nil 6. Balance under the Scheme not yet issued/allotted at end of period 277,016 7. Number and class of share(s) (amount of stock/debt securities) originally listed and the date of admission 126,220,994 ordinary shares admitted to listing on 8/3/2004 Please confirm total number of shares in issue at the end of the period in order for us to update our records: 159,372,573 Contact for queries: Nick Plummer, Ark Therapeutics Group plc, 79 New Cavendish Street, London W1W 6XBTelephone: 0207 388 7722 Person making return:Name: Nick PlummerPosition: Company Secretary This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Jul 200610:26 amRNSHolding(s) in Company
27th Jun 20063:34 pmRNSHolding(s) in Company
21st Jun 20067:01 amRNSRe Agreement
9th Jun 20061:58 pmRNSHolding(s) in Company
5th Jun 20063:44 pmRNSBlocklisting Interim Review
22nd May 20063:52 pmRNSDirectors' Shareholdings
19th May 20063:13 pmRNSRe Placing and Open Offer
27th Apr 20063:29 pmRNSResult of AGM
27th Apr 20067:03 amRNSPlacing and Open Offer
30th Mar 20067:01 amRNSRe Agreement
28th Mar 20063:22 pmRNSAnnual Information Update
9th Mar 20067:02 amRNSFinal Results
24th Feb 20064:44 pmRNSOption Awards
15th Feb 20067:01 amRNSRe Agreement
9th Feb 200611:18 amRNSDirector Share Dealing
19th Jan 200611:12 amRNSNotice of Results
16th Jan 20067:01 amRNSResearch Update
12th Jan 20067:00 amRNSUS Patent for Kerraboot
3rd Nov 20057:01 amRNSGrant for New Facility
28th Oct 20057:01 amRNSResearch Update
28th Oct 20057:01 amRNSRegulatory Application
28th Oct 20057:01 amRNSResearch Update
20th Oct 20057:00 amRNSArk Granted Licence
18th Oct 20057:00 amRNSResearch Update
5th Oct 20057:00 amRNSoxLDL approval
13th Sep 20054:37 pmRNSHolding(s) in Company
9th Sep 20055:00 pmRNSHolding(s) in Company
9th Sep 20053:46 pmRNSHolding(s) in Company
31st Aug 20057:01 amRNSInterim Results
24th Aug 20055:56 pmRNSHolding(s) in Company
5th Aug 20057:00 amRNSResearch Update
29th Jul 20056:00 pmRNSHolding(s) in Company
28th Jul 20053:48 pmRNSNotice of Results
25th Jul 20055:28 pmRNSInterest in Shares
21st Jul 20057:01 amRNSResearch Update
7th Jul 20057:00 amRNSBoard Appointment
23rd Jun 20058:41 amRNSDirector Shareholding
21st Jun 20057:00 amRNSResearch Update
14th Jun 20057:00 amRNSSigns Marketing Deal
8th Jun 20054:41 pmRNSListing Applications
7th Jun 20053:40 pmRNSHolding(s) in Company
19th May 20057:00 amRNSKerraboot Marketing Deal
4th May 20057:00 amRNSStrengthened Patent Position
3rd May 20056:11 pmRNSHolding(s) in Company
28th Apr 20054:25 pmRNSDoc re. Result of AGM
14th Apr 20057:00 amRNSResearch Update
7th Apr 20057:00 amRNSAppointment
1st Apr 20052:43 pmRNSNotice of AGM
1st Apr 20057:00 amRNSRe Agreement
23rd Mar 20057:00 amRNSResearch Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.